81230 CYP3A4 (cytochrome P450 family 3 subfamily A member 4) (eg, drug metabolism), gene analysis, common variant(s) (eg, *2, *22)

Name of the Procedure:

CYP3A4 (Cytochrome P450 Family 3 Subfamily A Member 4) Gene Analysis, Common Variant(s) (e.g., *2, *22)

Summary

This test analyzes the CYP3A4 gene to identify common genetic variants such as *2 and *22. These variants can affect how your body metabolizes certain medications.

Purpose

The CYP3A4 gene analysis is used to understand how a patient metabolizes drugs. This information helps to tailor medication types and dosages for more effective and safe treatment.

Indications

• Unexplained adverse drug reactions
• Lack of therapeutic effect from standard doses of medication
• Patients prescribed drugs primarily metabolized by CYP3A4 (e.g., certain statins, anticoagulants)
• Patients with a family history of drug metabolism issues

Preparation

• No specific preparation is usually needed.
• Inform the healthcare provider of any medications you are currently taking.

Procedure Description

1. A sample is collected, usually blood or saliva.
2. The sample is sent to a laboratory for DNA extraction.
3. The CYP3A4 gene is then analyzed for specific variants using techniques like PCR (Polymerase Chain Reaction).
4. Results are reviewed by a healthcare provider to determine their impact on drug metabolism.

Duration

The sample collection takes a few minutes. Laboratory analysis typically takes 1-2 weeks.

Setting

The sample collection is done in a healthcare provider's office or laboratory.

Personnel

• Phlebotomist or healthcare provider for sample collection
• Laboratory technicians and genetic specialists for analysis
• Pharmacist or healthcare provider for interpreting results

Risks and Complications

• Minimal risk associated with blood draw, such as bruising or infection.
• Very low risk with saliva collection.

Benefits

• Personalized medication management
• Reduced risk of adverse drug reactions
• Improved efficacy of prescribed medications

Recovery

• No recovery time is needed.
• Patients can resume normal activities immediately after sample collection.

Alternatives

• Empirical medication adjustments based on clinical response.
• Pharmacogenetic tests for other drug-metabolizing enzymes if CYP3A4 is not suspected to play a major role.

Patient Experience

• Mild discomfort during blood draw, if applicable.
• No pain or discomfort expected during saliva sample collection.
• Peace of mind knowing that medication regimens can be more effectively managed.

By understanding how your body processes medications, this test helps ensure that you receive the safest and most effective treatments tailored to your genetic profile.